Fiala

Peptide library › Digestive health

Apraglutide

In clinical trialsDigestive health

Experimental once-weekly GLP-2 medicine for short bowel syndrome.

What people use it for

What Apraglutide does in the body

A long-acting GLP-2 analog designed to help the gut lining grow and absorb more, with weekly rather than daily injections.

Strength of evidence

Moderate: Phase 3 results showed reduced need for IV nutrition, with some remaining questions.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

Investigational. Not approved by the FDA.

How it's taken

Route: Injection under the skin, once weekly (in trials)

How long it lasts (half-life): Long-acting; designed for weekly dosing

Keep track of Apraglutide privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Apraglutide in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Digestive health